Dolphin Medical Services Board Meeting for Q2 FY27 Results

In continuation of the company's earlier intimation, and in compliance with the Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 and the Company's "Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in Securities by Insiders", the Trading Window for dealing in the securities of the Company for all Designated Persons, including Insiders, had been closed with effect from October 01, 2026. The Trading Window will remain closed until 48 hours after the publication of the financial results.

The disclosure is addressed to BSE Limited, Department of Corporate Services, P. J. Tower, Dalal Street, Mumbai - 400 020, Maharashtra, India.

The letter is signed by Rajesh Kumar Mallour, Director (DIN: 08125774) on behalf of Dolphin Medical Services Limited (CIN: L24239TG1992PLC014775). The company's registered office is located at Level 3, Plot No 13, Greenlands Colony, Besides Flyover Gachibowli, Hyderabad– 500032.